Therefore, we performed p53 immunohistochemistry (IHC) to estimate p53 mutational status, which may be associated with high-grade tumor morphology and a worse overall prognosis with the goal to aid in diagnostic challenges for pathologists. The gene discussed is TP53; the disease is neoplasm.